Login / Signup

Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy.

Patrick EllsworthSheh-Li ChenNigel S KeyYasmina AbajasAlice Ma
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • early onset
  • patient reported outcomes